Multiple functions of HMGB1 in cancer

被引:2
|
作者
Lv, Guangyao [1 ]
Yang, Menglin [2 ]
Gai, Keke [1 ]
Jia, Qiong [1 ]
Wang, Zhenzhen [1 ]
Wang, Bin [1 ]
Li, Xueying [3 ]
机构
[1] Binzhou Med Univ Hosp, Dept Pharm, Binzhou, Shandong, Peoples R China
[2] Marine Biomed Res Inst Qingdao, Qual Management Dept, Qingdao, Peoples R China
[3] Binzhou Polytech, Sch Hlth, Binzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
HMGB1; cancer; chemotherapy resistance; autophagy; immunotherapy; GROUP BOX 1; IMMUNOGENIC CELL-DEATH; HMGB1-MEDIATED AUTOPHAGY; PROTEIN HMGB1; ANGIOGENESIS; CHEMOTHERAPY; RESISTANCE; EXPRESSION; PROGRESSION; MIGRATION;
D O I
10.3389/fonc.2024.1384109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High mobility group box 1 (HMGB1) is a nuclear DNA-binding protein with a dual role in cancer, acting as an oncogene and a tumor suppressor. This protein regulates nucleosomal structure, DNA damage repair, and genomic stability within the cell, while also playing a role in immune cell functions. This review comprehensively evaluates the biological and clinical significance of HMGB1 in cancer, including its involvement in cell death and survival, its potential as a therapeutic target and cancer biomarker, and as a prosurvival signal for the remaining cells after exposure to cytotoxic anticancer treatments. We highlight the need for a better understanding of the cellular markers and mechanisms involved in the involvement of HMGB1in cancer, and aim to provide a deeper understanding of its role in cancer progression.
引用
下载
收藏
页数:12
相关论文
共 50 条
  • [1] HMGB1 in inflammation and cancer
    Shumin Wang
    Yi Zhang
    Journal of Hematology & Oncology, 13
  • [2] HMGB1 in inflammation and cancer
    Wang, Shumin
    Zhang, Yi
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [3] HMGB1 IN THE PATHOGENESIS OF COLORECTAL CANCER
    Hapca, Sandra
    Brice, Daniel P.
    Berry, Susan
    Murray, Graeme I.
    McLean, Mairi H.
    GUT, 2018, 67 : A192 - A192
  • [4] Role of HMGB1 in inflammation and cancer
    Yanai, Hideyuki
    Taniguchi, Tadatsugu
    CYTOKINE, 2017, 100 : 57 - 57
  • [5] HMGB1 and RAGE in Inflammation and Cancer
    Sims, Gary P.
    Rowe, Daniel C.
    Rietdijk, Svend T.
    Herbst, Ronald
    Coyle, Anthony J.
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 28, 2010, 28 : 367 - 388
  • [6] The role of HMGB1 in digestive cancer
    Chen, Xiangqi
    Liu, Qian
    Wu, Enqing
    Ma, Zhiyuan
    Tuo, Biguang
    Terai, Shuji
    Li, Taolang
    Liu, Xuemei
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [7] Exosomal HMGB1 Promoted Cancer Malignancy
    Wang, Jiaan-Der
    Wang, Ya-Yu
    Lin, Shih-Yi
    Chang, Cheng-Yi
    Li, Jian-Ri
    Huang, Shi-Wei
    Chen, Wen-Ying
    Liao, Su-Lan
    Chen, Chun-Jung
    CANCERS, 2021, 13 (04) : 1 - 16
  • [8] HMGB1 as the therapeutic target in gastric cancer
    Takaki, Wataru
    Konishi, Hirotaka
    Arita, Tomohiro
    Kosuga, Toshiyuki
    Shiozaki, Atsushi
    Nakanishi, Masayoshi
    Kubota, Takeshi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    CANCER SCIENCE, 2021, 112 : 429 - 429
  • [9] The dual role of HMGB1 in pancreatic cancer
    KangRui
    TangDaolin
    胰腺病学杂志(英文), 2018, 1 (01) : 19 - 20-21-22-23-24
  • [10] Role of Serum HMGB1 in Prostate Cancer
    Solakhan, Mehmet
    Cicek, Hulya
    Benlier, Necla
    Yildirim, Zeliha
    Sever, Ozlem Nuray
    Orhan, Nun
    Yildirim, Mustafa
    EUROPEAN JOURNAL OF THERAPEUTICS, 2020, 26 (02): : 108 - 112